ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Packaging Technical Transfer Lead at Revolution Medicines - ApplyBlast

Packaging Technical Transfer Lead

Revolution Medicines

28 days ago

3.5 on Glassdoor

Redwood City, California, United States

Hybrid

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

This role leads and oversees packaging technical transfers, line qualification, and lifecycle management for commercial products and CMO sites. The successful candidate serves as the primary technical contact for assigned CMOs, partnering cross-functionally to manage packaging performance, investigate issues, and maintain inspection readiness. The position involves assessing site capabilities, managing validation activities, and driving continuous improvement initiatives throughout the product lifecycle.

Responsibilities

Lead packaging technical transfers and equipment qualification activities
Manage packaging lifecycle and post-approval changes for commercial products
Oversee packaging operations and compliance at external CMO sites

Skills

Qualifications

Bachelor's degree in Packaging EngineeringMaster's degree in Packaging ScienceEngineering discipline

About Revolution Medicines

revmed.com

Headquarters

Redwood City, California, United States

Company Size

201-500 employees

Founded

2014

View Profile

Revolution Medicines (RevMed) is a biopharmaceutical company dedicated to discovering, developing, and delivering novel targeted medicines for patients with cancer. Their mission focuses specifically on "revolutionizing treatment for patients with RAS‑addicted cancers" through precision-targeted therapies. The company emphasizes a science-driven, end-to-end approach from discovery to delivery. RevMed brands its team as "Revolutionaries" committed to transforming outcomes for people with RAS‑driven tumors.